Transverse myelopathy in systemic lupus erythematosus: An analysis of 14 cases and review of the literature

Annals of the Rheumatic Diseases

Volumn 59, Issue 2, 2000, Pages 120-124

  Kovacs, Birgit ^a   Lafferty, Thomas L ^b   Brent, Lawrence H ^a   DeHoratius, Raphael J ^b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; HUMAN; PLASMAPHERESIS; PREVALENCE; PRIORITY JOURNAL; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; AGED; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; METHYLPREDNISOLONE; MIDDLE AGED; MYELITIS, TRANSVERSE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0034108670     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.2.120     Document Type: Article

References (51)

1. 1 West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am. 1994;20:129-58.
2. 2 West SG. Lupus and the central nervous system. Curr Opin Rheumatol 1996;8:408-14.
3. 3 Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myeltitis: Incidence and etiologic considerations. Neurology. 1981;31:966-71.
4. 4 Allen IV, Millar JHD, Kirk J, Shillington RKA. Systemic lupus erythematosus clinically resembling multiple sclerosis and with unusual pathological and ultrastructural features. J Neurol Neurosurg Psychiatry 1979;42:392 401.
5. 5 Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. 6 Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
7. 7 Andrianakos AA, Duffy J, Suzuki M, Sharp JT. Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature. Ann Intern Med 1975;83:616-24.
8. 8 April RS, Vansonnenberg E. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Neurology 1976;26:1066-70.
9. 9 Kinney E, Berdoff RL, Nagbushan SR, Fox LM. Devic's syndrome and systemic lupus erythematosus, A case report with necropsy. Arch Neurol 1979;36:643-4.
10. 10 Warren RW, Kredich DW. Transverse myelitis and acute central nervous system manifestations of systemic lupus erythematosus. Arthritis Rheum 1984;27:1058-60.
11. 11 Hardie KJ, Isenberg DA. Tetraplegia as a presenting feature of systemic lupus erythematosus complicated by pulmonary hypertension. Ann Rheum Dis 1985;44:491-3.
12. 12 Zerbini CA, Fidelix TS, Rabello GD. Recovery from transverse myelitis of systemic lupus erythematosus with steroid therapy [letter]. J Neurol. 1986;233:188-9.
13. 13 Jabs DA, Miller NR, Newman SA, Johnson MA, Stevens MB. Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol 1986;104:564-86.
14. 14 de Brum-Fernandes AJ, Lucena-Fernandes MF, Levy Neto M, Cossermelli W. Myelitis in systemic lupus erythematosus [letter]. Arthritis Rheum 1987;30:238-9.
15. 15 Sands ML, Ryczak M, Brown RB. Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus. J Rheumatol 1988;15: 862-4.
16. 16 Marabani M, Zoma A, Hadley D, Sturrock RD. Transverse myelitis occurring during pregnancy in a patient with systemic lupus erythematosus. Ann Rheum Dis 1989;48: 160-2.
17. 17 Propper DJ, Bucknall RC. Acute transverse myelopathy complicating systemic lupus erythematosus. Ann Rheum Dis. 1989;48:512-15.
18. 18 Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 1990;17:89-92.
19. 19 Lavalle C, Pizarro S, Drenkard C, Sanchez-Guerrero J, Alarcon-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies [see comments]. J Rheumatol 1990;17:34-7.
20. 20 Misteli M, Conen D. [Acute transverse myelitis in systemic lupus erythematosus: successful therapy with cyclophosphamide and prednisone]. Schweiz Med Wochenschr 1991;121:77-80.
21. 21 Barile L, Lavalle C. Transverse myelitis in systemic lupus erythematosus-the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol 1992;19:370-2.
22. 22 Simeon-Aznar CP, Tolosa-Vilella C, Cuenca-Luque R, Jordana-Cumajuncosa R, Ordi-Ros J, Busch-Gil JA. Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging. Br J Rheumatol 1992;31:555-8.
23. 23 Tola MR, Granieri E, Caniatti L, Paolino E, Monetti C, Dovigo L, et al. Systemic lupus erythematosus presenting with neurological disorders. J Neurol 1992;239:61-4.
24. 24 Szer IS, Miller JH, Rawlings D, Shaham B, Bernstien B. Cerebral perfusion abnormalities in children with central nervous system manifestations of lupus detected by single photon emission computed tomography. J Rheumatol 1993;20:2143-8.
25. 25 Klaiman MD, Miller SD, Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report. Am J Phys Mod Rehabil 1993;72:158-61.
26. 26 Cordeiro MF, Lloyd ME, Spalton DJ, Hughes GR. Ischaemic optic neuropathy, transverse myelitis, and epilepsy in an anti-phospholipid positive patient with systemic lupus erythematosus [letter]. J Neurol Neurosurg Psychiatry 1994;57:1142-3.
27. 27 Salmaggi A, Lamperti E, Ecoli M, Venegoni E, Bruzzone MG, Riccio G, et al. Spinal cord involvement and systemic lupus erythematosus: clinical and magnetic resonance findings in 5 patients [published erratum appears in Clin Exp Rheumatol 1994;12;695]. Clin Exp Rheumatol 1994;12: 389-94.
28. 28 Kira J, Goto I. Recurrent opticomyelitis associated with anti-DNA antibody. J Neurol Neurosurg Psychiatry 1994; 57:1124-5.
29. 29 Valesini G, Priori R, Francia A, Balestrieri G, Tincani A, Airo P, et al. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. Springer Semin Immunopathol 1994;16:313-21.
30. 30 Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol 1995;242:326-31.
31. 31 Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 1995;98;32-41.
32. 32 Baca V, Sanchez-Vaca G, Martinez-Muniz I, Ramirez-Lacayo M, Lavalle C. Successful treatment of transverse myelitis in a child with systemic lupus erythematosus. Neuropediatrics 1996;27:42-4.
33. 33 Chan KF, Boey ML. Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus 1996;5:294-9.
34. 34 O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DPE, Thompson EJ, et al. Clinical, CSF, and MRI finding in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996;60:382-7.
35. 35 Radis CD, Callis KP. Systemic lupus erythematosus with membranous glomerulonephritis and transverse myelitis associated with anabolic steroid use. Arthritis Rheum 1997;40:1899-902.
36. 36 Sanchez-Rodriguez A, Oterino JAM, Hernandez PA. Lupus Myelitis. Arch Intern Med 1998;158:2267-8.
37. 37 Mok CG, Lau CS, Chan EY, Wong RW. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 1998;25;467-73.
38. 38 Schantz V, Oestergaard LL, Junker P. Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome. J Rheumatol 1998;25:1425-8.
39. 30 Deodhar AA, Hochenedel T, Bennett RM. Longitudinal involvement of the spinal cord in a patient with lupus related transverse myelitis. J Rheumatol 1999;26:446-9.
40. 40 Gibson TP, Dibona GF. Use of the American Rheumatism Association's preliminary criteria for the classification of systemic lupus erythematosus. Ann Intern Med 1972;77: 754-6.
41. 41 Smyth AE, Bruce IN, McMillan SA, Bell AL. Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome. Ulster Med J. 1996;65:91-4.
42. 42 Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-65.
43. 43 Kenik JG, Krohn K, Kelly RB, Bierman M, Hammeke MD, Hurley JA. Transverse myelitis and optic neuritis in systemic lupus erythematosus: a case report with magnetic resonance imaging findings. Arthritis Rheum 1987:30:947-50.
44. 44 Tartaglino LM, Croul SE, Flanders AE, Sweeney JD, Schwartzman RJ, Liem M, et al. Idiopathic acute transverse myelitis: MR imaging findings. Radiology 1996;201:661-9.
45. 45 Baca V, Lavalle C, Garcia R, Catalan T, Sauceda JM, Sanchez G, et al. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol 1999;26:432-9.
46. 46 Berlanga B, Rubio FR, Moga I, Pac V. Response to intravenous cyclophosphamide treatment in lupus myelopathy [letter]. J Rheumatol 1992;19:829-30.
47. 47 Tola MR, Casetta I, Granieri E, Caniatti LM, Monetti VC, Pascarella R. Systemic lupus erythematosus related recurrent transverse myelitis in a patient with myasthenia gravis and multiple sclerosis. Eur Neurol 1996;36:327-8.
48. 48 Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, et al. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 1999;26: 1715-20.
49. 49 Zivelin A., Gitel S, Griffin JH, Xu X, Fernandez JA, Martinowitz U, et al. Extensive venous and arterial thrombosis associated with an inhibitor of activated protein C. Blood 1999;94:895-901.
50. 50 Cuadrado MJ, Tinahones F, Camps MT, De Ramon E, Gomez-Zumaquero JM, Mujic F, et al. Antiphospholipid, anti-β2-glycoprotein-I and anti-oxidized-low-density-lipoprotein antibodies in antiphospholipid syndrome. Q J Med 1998;91:619-26.
51. 51 Devic E. Myelite subaigue compliquee de nevrite optique. Bull Med 1894;8:1033-4.